FSD Pharma Inc Price/Book
Cos'è Price/Book di FSD Pharma Inc?
Price/Book di FSD Pharma Inc è 0.03
Qual è la definizione di Price/Book?
Il rapporto Price to book rappresenta il rapporto tra il valore delle azioni di una società e il valore contabile per azione.
The price to book ratio, or P/B ratio, is a financial ratio used to compare a company's current market price to its book value. It is also sometimes known as a market to book ratio or price to equity ratio. The calculation of a price to book ratio can be performed in two ways. It can be calculated as the company's market capitalization divided by the company's total book value from its balance sheet. It can also be calculated using per-share values and dividing a company's current share price by the book value per share (i.e. its book value divided by the number of outstanding shares).
The P/B ratio varies between industries. The industries that require more infrastructure capital (for each dollar of profit) will usually trade at P/B ratios much lower than, for example, consulting firms. P/B ratios are commonly used to compare banks, because most assets and liabilities of banks are constantly valued at market values. A higher P/B ratio implies that investors expect management to create more value from a given set of assets, all else equal (and/or that the market value of the firm's assets is significantly higher than their accounting value).
P/B ratios do not, however, directly provide any information on the ability of the firm to generate profits or cash for shareholders. This ratio also gives some idea of whether an investor is paying too much for what would be left if the company went bankrupt immediately. For companies in distress, the book value is usually calculated without the intangible assets that would have no resale value. In such cases, P/B should also be calculated on a "diluted" basis, because stock options may well vest on sale of the company or change of control or firing of management.
Price/Book di aziende nel Technology settore su NASDAQ rispetto a FSD Pharma Inc
Cosa fa FSD Pharma Inc?
fsd pharma inc., through its subsidiary, fv pharma inc., produces medical cannabis in canada. the company focuses on the development of indoor grown pharmaceutical grade cannabis; and research and development of various cannabinoid-based treatments for central nervous system disorders and autoimmune diseases of the skin, gi tract, and musculoskeletal system, such as chronic pain. fsd pharma inc. has strategic alliance agreements with scicann therapeutics inc., canntab therapeutics, and solarvest bioenergy inc. the company was founded in 1998 and is headquartered in toronto, canada.
Aziende con price/book simili a FSD Pharma Inc
- RM2 International S.A ha Price/Book di 0.03
- Cypress Environmental Partners L.P ha Price/Book di 0.03
- Ethernity Networks ha Price/Book di 0.03
- Master Glory ha Price/Book di 0.03
- Tencent ha Price/Book di 0.03
- Seacoast Commerce Banc ha Price/Book di 0.03
- FSD Pharma Inc ha Price/Book di 0.03
- Leju Ltd ha Price/Book di 0.03
- Datagroup Se ha Price/Book di 0.03
- Celanese ha Price/Book di 0.03
- Tubesolar Ag Inh O.N ha Price/Book di 0.04
- e Athena ha Price/Book di 0.04
- Sibanye Stillwater ha Price/Book di 0.04